[1]
L. F. C. de Almeida, L. F. L. da Silva, A. C. P. Vieira, A. P. Cappellaro, and F. Batalini, “Metronomic versus standard fixed dosing chemotherapy in human epidermal growth factor receptor-type 2-negative metastatic breast cancer: a reconstructed individual patient data meta-analysis”, MAST, vol. 35, no. suppl.1, Feb. 2026.